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ORIGINAL ARTICLEExposure to Solar UVR Suppresses
Cell-Mediated Immunization Responses
in Humans: The Australian Ultraviolet
Radiation and Immunity Study
Ashwin Swaminathan1,2, Simone L. Harrison3, Natkunam Ketheesan4, Christel H.A. van den Boogaard3,5,
Keith Dear6, Martin Allen7, Prue H. Hart8, Matthew Cook9,10 and Robyn M. Lucas1,11Animal and human studies show that exposure to solar-simulated UVR is immunomodulatory. Human studies
that used natural sun exposure and controlled for confounding are rare. We immunized 217 healthy adults (age
range ¼ 18e40 years) with a T-celledependent antigen, keyhole limpet hemocyanin, and measured personal
clothing-adjusted UVR exposure (for 5 days before and after immunization), lifetime cumulative UVR exposure,
serum 25-hydroxyvitamin D concentration at immunization, and potential confounding factors. We tested
cellular and humoral immune responses in relation to UVR exposure. The delayed-type hypersensitivity
response to keyhole limpet hemocyanin recall challenge was lower in individuals with higher personal
clothing-adjusted UVR exposure on the day before immunization (P ¼ 0.015) and during intervals spanning the
day before to 2e3 days after immunization. There was an incremental increase in T helper type 17 cells (as a
proportion of CD4þ T cells) from preimmunization to postimmunization in the high, compared with the low,
personal clothing-adjusted UVR exposure group (0.31% vs. e0.39%, P ¼ 0.004). Keyhole limpet hemocyanin-
specific antibody titers were not associated with acute or cumulative UVR exposure or serum 25-
hydroxyvitamin D levels. Higher UVR exposure at antigen sensitization was associated with a reduced
delayed-type hypersensitivity response and altered T helper type 17 kinetics. This has implications for the
effectiveness of vaccinations and susceptibility to infections that rely on cell-mediated immune responses.
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then, it has become clear that UVR exposure has complex ef-
fects on the human immune system—suppressing antigen-
specific cell-mediated immune processes but up-regulating
aspects of innate immunity (Glaser et al., 2009; Hart and
Norval, 2018; Schwarz, 2008). UVR exposure also induces
the synthesis of vitamin D, and the active form of this pre-
hormone also has regulatory effects on immune function (Hart
et al., 2011).
The effects of UVR on responses to infections or vaccina-
tion have been studied in animals (reviewed in Sleijffers
et al., 2004). Overall, UVR exposure appears to decrease
animals’ resistance to intracellular infections and response to
vaccinations that require integrity of T helper (Th) type 1
cell-mediated immune processes. Host resistance is affected
both locally (at the site of infection or UVR exposure) and
systemically for noncutaneous disease (e.g., murine leukemia
virus). Other animal studies have shown that UVR
impairs humoral responses via suppressive effects on
T-follicular-helper cell function and germinal center forma-
tion (Chacόn-Salinas et al., 2011) and the promotion of reg-
ulatory T cells (Wang et al., 2008).
To date, controlled human studies of the immunomodu-
latory properties of UVR exposure have used laboratory
irradiation with artificial UVR that does not closely simulate
the intensity, spectrum, and skin exposure of solar UVR
experienced under natural conditions (Sleijffers et al., 2001),
or they have used proxies for exposure to natural solar UVR,estigative Dermatology. This is an open access
-nc-nd/4.0/). www.jidonline.org 1545
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1546such as season or latitude, without individual exposure data
(Colditz et al., 1994; Linder et al., 2011).
Here, we describe the results of the Australian Ultraviolet
Radiation and Immunity (AusUVI) Study, which was designed
to assess the influence of natural sun exposure on the sensi-
tization phase of a primary immune response to a model
protein antigen, keyhole limpet hemocyanin (KLH)
(Swaminathan et al., 2014). We measured the UVR exposure
experienced during daily living in two cohorts of healthy
young adults residing in regions with very different ambient
UVR conditions, and we measured potential confounding
factors, including physical activity, psychological state, and
ethnicity. We measured T-celledependent antibody
responses, differentiation of T cells to effectors, and delayed-
type hypersensitivity (DTH) responses as a composite
measure of immunity.
RESULTS
Participant characteristics
We recruited 222 healthy adult participants but excluded five
from analysis because screening tests suggested possible
infection at the time of KLH immunization. The characteris-
tics of the remaining 217 participants are summarized in
Table 1. Participants from Canberra were more likely than
participants from Townsville to have a university qualifica-
tion. Townsville participants were more likely to report
occupational settings described as “half indoors/half out-
doors,” were less likely to be employed predominantly “in-
doors,” were less likely to report light recent physical activity,
and had higher melanin density at the (sun-protected) upper
inner arm than Canberra participants.
Measurement of acute UVR exposure
The 10-day total clothing-adjusted UVR (ca-UVR) exposure
(in standard erythemal doses [SEDs]) was approximately one
third the unadjusted dosimeter measurement, although this
ratio varied by season and study site (Figure 1). The largest
difference in ca-UVR between study sites occurred in the
winter months (June through August) (Townsville ¼ 2.3 SEDs
vs. Canberra ¼ 0.32 SEDs, P < 0.001). Participants with
northern European ethnicity or an outdoor work setting had
higher ca-UVR exposure. Each unit increase in ca-UVR
exposure was linearly associated with increasing serum 25-
hydroxyvitamin D (25[OH]D) of 3.9 nmol/L (95% confi-
dence interval [CI] ¼ 2.4e5.5, P < 0.001) sampled at day 8
(see Supplementary Table S1 online).
On the day before immunization (day 7), on average, the
forearm (i.e., immunization site) was uncovered for 64.4% of
the recorded day (7 AMe7 PM), with differences by study site
(Townsville ¼ 81.6% vs. Canberra ¼ 46.9%, P < 0.001).
Measurement of lifetime cumulative UVR exposure
Silicone skin cast scores were normally distributed (mean ¼
3.7, standard deviation ¼ 1.0). In a mutually adjusted
multiple regression model, higher ordinal skin cast score
was associated with Townsville residence (adjusted odds
ratio ¼ 2.3, 95% CI ¼ 1.4e3.7; P ¼ 0.001), older age
(adjusted odds ratio ¼ 1.1 per year, 95% CI ¼ 1.08e1.18;
P < 0.001), male sex (adjusted odds ratio ¼ 2.8, 95%
CI ¼ 1.6e4.8; P < 0.001), and northern European parentalJournal of Investigative Dermatology (2019), Volume 139ethnicity (adjusted odds ratio ¼ 3.3, 95% CI ¼ 1.9e5.8;
P < 0.001).
Cell-mediated immune response
DTH testing. DTH responses were recorded in 211 (97%)
participants; 6 participants did not attend the final study visit
for the DTH response to be measured. One extreme DTH
response (29.5 mm) (55% higher than the next measured
response) was excluded, given its disproportionate influence
on regression coefficients. The mean of the remaining DTH
responses was 7.0 (standard deviation ¼ 4.0) mm. Females
had significantly larger DTH responses than males (7.4 mm
vs. 6.5 mm, P ¼ 0.038). Other putative immunomodulatory
factors were not significantly associated with the DTH
response (see Supplementary Table S2 online).
Associations between personal UVR exposure and DTH
response. We analyzed the association between ca-UVR
exposure around the time of KLH immunization and subse-
quent DTH responses measured at day 31. We used the ca-
UVR for each day that the dosimeter was worn and for
combinations of days (by summing the individual daily ca-
UVR exposures) as per the matrix shown in Supplementary
Table S3 online.
In univariate analyses (Table 2), we observed a significantly
reduced DTH response in association with higher ca-UVR on
day 7 (the day before immunization) (p ¼ 0.019) (Figure 2).
Lifetime UVR exposure (using a dichotomous skin cast score
cut point of 3.5, P ¼ 0.15) and serum 25(OH)D levels (P ¼
0.66) were not associated with DTH response. Results were
similar in the multiple regression model that included other
immunomodulatory factors, except that ca-UVR over days
7e10 (P ¼ 0.039) and 7e11 (P ¼ 0.025) were also inde-
pendent determinants of DTH response. The regression co-
efficients for all aggregated ca-UVR exposure variables
showed inverse associations with DTH response. Adjustment
for clothing coverage of the forearm (immunization site) on
day 7 as a confounding or interaction variable did not change
the association between ca-UVR and DTH response.
Effector T-cell lymphocyte subset assays. We enumerated
effector CD4þ T cells from a subset (55/216, w25%) of
participants with extremes of personal ca-UVR exposure.
Mean 10-day aggregated ca-UVR exposures in the high (n ¼
27) and low (n ¼ 28) groups were 5.3 and 0.36 SEDs,
respectively (P < 0.001). Age and sex distribution were not
statistically different from the overall sample, although the
low-UVR group included more participants from Canberra.
We characterized CD4þ T cells according to effector
function and stratified by UVR exposure group and KLH-
immunization status (see Supplementary Table S4 online).
There were no significant differences in the abundance of
effector or regulatory T-cell subsets at baseline between in-
dividuals with high or low UVR exposure. There was vari-
ability between individuals with regard to effector T-cell
subsets, and because the impact of KLH immunization on
overall effector abundance was expected to be small, we
analyzed the responses for longitudinal changes within in-
dividuals comparing pre- and post-KLH immunization. From
preimmunization to postimmunization, we observed a sig-
nificant difference in Th17 as a proportion of all CD4þ T cells
Table 1. Characteristics of eligible volunteer participants in the AusUVI Study
Characteristic Canberra Townsville Overall
Number, n (%) 108 (49.8) 109 (50.2) 217 (100)
Female, n (%) 69 (63.9) 68 (62.4) 137 (63.1)
Age in years, mean (SD) 29.3 (5.7) 26.4 (6.4) 27.8 (6.2)
Range (18.3e40.9) (18.2e40.6) (18.2e40.9)
Parental ethnicity, n (%)
Northern European (both parents) 71 (65.7) 80 (73.4) 151 (69.6)
Highest education qualification, n (%)
High school (not matriculated) 1 (0.9) 2 (1.8) 3 (1.4)
Higher school certificate 10 (9.3) 54 (48.7) 63 (29.2)
Apprenticeship, certificate, or diploma 7 (6.4) 11 (9.9) 18 (8.2)
Bachelor’s degree 54 (50.0) 27 (24.3) 80 (37.0)
Postgraduate degree 36 (33.3) 17 (15.3) 52 (24.1)
Current smoker, n (%) 4 (3.7) 8 (7.3) 12 (5.5)
Work environment, n (%)
Indoors 102 (94.4) 90 (82.6) 192 (88.5)
Half indoors/half outdoors 5 (4.6) 16 (14.7) 21 (9.7)
Outdoors 1 (0.9) 3 (2.8) 4 (1.8)
Body mass index in kg/m2, mean (SD) 23.9 (3.3) 23.8 (4.2) 23.8 (3.7)
Recent physical activity category, n (%)
Light 11 (10.2) 2 (1.9) 13 (6.0)
Moderate 37 (34.3) 34 (31.5) 71 (32.9)
High 60 (55.6) 72 (66.7) 132 (61.1)
Psychological—global scores
Profile of Mood States, mean (SD) 1.9 (13.9) 1.4 (13.1) 1.6 (13.5)
Mental Health Inventory, mean (SD) 168.1 (19.2) 168.4 (21.2) 168.2 (20.2)
Cutaneous melanin density at visit 2
Left inner arm, mean % (SD) 3.1 (1.4) 3.5 (1.2) 3.3 (1.3)
Left upper cheek, mean % (SD) 4.0 (0.77) 4.0 (0.77) 4.0 (0.77)
Serum 25(OH)D in nmol/L, visit 2, mean (SD)
Winter (JuneeAugust) 39.7 (20.1) 80.0 (20.9) 65.7 (28.3)
Spring (SeptembereNovember) 64.1 (20.9) 95.4 (23.2) 74.8 (26.2)
Summer (DecembereFebruary) 82.1 (19.8) 98.6 (26.0) 89.9 (24.1)
Autumn (MarcheMay) 76.2 (33.2) 93.7 (26.9) 84.3 (31.4)
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; AusUVI, Australian Ultraviolet Radiation and Immunity Study; SD, standard deviation.
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0.31%) and the low ca-UVR exposure group (mean decrease
of 0.39%, P ¼ 0.004) (Figure 3). We did not detect any dif-
ferences between the UVR exposure groups in the pre-
immunization to postimmunization periods for other effector
or regulatory T-cell populations. Additionally, there was no
correlation between an individual’s DTH response and the
change in Th17 cell proportions from preimmunization to
postimmunization.
KLH-specific antibody response
The anti-KLH IgG1 and IgG2 titers on days 15 and 29 were
higher than the preimmunization baseline levels (day 8) (P <
0.001). There were no significant associations between ca-
UVR exposure on any day or combination of days and anti-
KLH IgG1 or IgG2 titers at day 29 in multiple regression
models (see Supplementary Tables S5 and S6 online).
Furthermore, neither serum 25(OH)D level nor cumulative
UVR exposure was significantly associated with anti-KLH
IgG1 or IgG2 responses in the best-fitting multiple regres-
sion models.DISCUSSION
The AusUVI Study is the largest study to date to have assessed
the immunomodulatory effect of naturally acquired solar
UVR on an immunization response in humans. We found that
higher natural solar UVR exposure on the day before KLH
immunization and the aggregate exposure from the day
before to 2 and 3 days after immunization were associated
with a reduced antigen-specific in vivo cell-mediated
response, as assessed by DTH analysis performed 3 weeks
later. This suggests that UVR exposure during the sensitiza-
tion phase of the immune response is critical in inducing
antigen-specific immunotolerance. One plausible mecha-
nism would be impaired antigen processing and promotion
of a regulatory T-cell environment within the draining lymph
node (Schwarz, 2008). We also observed a small but signif-
icant difference in the preimmunization to postimmunization
change in Th17 cells as a proportion of all CD4þ T cells in
individuals with low compared with high recent UVR expo-
sure. We found no association between response to immu-
nization (either cell-mediated or humoral) and lifetime UVR
exposure or 25(OH)D level.www.jidonline.org 1547
Figure 1. Aggregated 10-day
clothing-adjusted UVR exposure for
study participants from temperate
(Canberra) and tropical (Townsville)
study sites. The 10-day aggregated
UVR doses for wrist dosimeter
measurement (total UVR exposure)
and clothing-adjusted UVR exposure
for Canberra and Townsville study
participants as they were recruited
through the year. SED, standard
erythemal dose.
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immunological work in this field, because we used KLH, a
protein derived from the giant keyhole limpet, Megathura
crenulata, which is a potent immunogen in humans. It is
phylogenetically distant from mammalian proteins and pro-
duces a robust primary immune response in humans, with
few false positive responses. Before and after immunization
with KLH, we undertook comprehensive immune testing,
innovative personal UVR exposure monitoring, and mea-
surement of potential immunomodulatory confounding fac-
tors (Van Loveren et al., 1999).
Limitations of this study include the inability to adjust for
any effect of sunscreen application on total personal UVR
exposure. Sunscreen protection varies according to the
thickness and distribution of application, sun protection
factor, and decay in effectiveness over time. Optimal sun-
screen use (at 2 mg/cm2) has been shown to prevent solar
UVR immunosuppression, as measured by contact hyper-
sensitivity responses (Narbutt et al., 2018). There is currently
no validated method for correcting UVR exposure for sun-
screen use based on questionnaire-derived data. Addition-
ally, our exposure monitoring was restricted to the antigen
sensitization phase of the immune response, and therefore
we cannot comment on the potential effect of sun exposure at
the time of the elicitation phase of the DTH response.
Nevertheless, extending the length of time for wearing the
electronic dosimeter and/or completion of the sun diary
would have been an additional participant burden that likely
would have reduced compliance and the reliability of data
recording.
Kelly et al. (2000) found a dose-dependent reduction in
contact hypersensitivity response at 21 days after a single
dose of solar-simulated radiation administered 24 hours
before sensitization with a contact allergen (Kelly et al.,
2000). The effect was stronger in lighter skin types andJournal of Investigative Dermatology (2019), Volume 139present at sub-erythemal doses. Damian et al. (1999)
administered sub-erythemal solar-simulated radiation before
a nickel challenge (in allergic participants) rather than at first
exposure to the antigen. There was a significant reduction
in the contact hypersensitivity response after 1 day of
solar-simulated radiation, reaching maximal levels with 2
days of exposure and sustained suppression with up to 5 days
of exposure (Damian et al., 1999). Other relevant in vivo
models have used longer UVR exposure protocols (i.e., up to
weeks), making it difficult to identify specific critical days for
exposure before antigen sensitization (Damian and Halliday,
2002; Fourtanier et al., 2005). Our findings of a modest
immunosuppressive effect of solar UVR, compared with the
larger effects seen in experimental studies using artificial
UVR, may relate to the comparatively low (i.e., typically sub-
erythemal) UVR doses observed in this study.
We found no association between measures of acute per-
sonal UVR exposure and anti-KLH IgG1 or IgG2 titer at 21
days after immunization. This is consistent with a previous
study, in which participants were randomized to a control
group or to receive 5 days of whole-body UVB irradiation,
before hepatitis B vaccination (Sleijffers et al., 2001). There
were no significant differences in hepatitis B-specific IgG or
T-cell lymphocyte responses between groups up to 60 days
after initial vaccination, although natural killer cell activity
and contact hypersensitivity responses were reduced in the
irradiated group.
In the AusUVI Study, participants in the low ca-UVR
exposure group had a higher percentage of Th17 cells (as a
proportion of all CD4þ T cells) before immunization than
those in the high exposure group (0.75% vs. 0.56%. P ¼
0.13). Although this was not statistically significant, it is
consistent with a more reactive T-cell milieu, and perhaps
increased risk of autoimmunity, with low sun exposure (Lucas
et al., 2015). When comparing Th17 cell percentages before
Table 2. Association between clothing-adjusted UVR exposure and DTH response
Day
Univariate Linear Regression Multivariable Linear Regression1
n b (95% CI), 3102 P n b (95% CI), 3102 P
Individual study day
3 198 e3.7 (e108 to 32) 0.29 183 e59 (e150 to 32) 0.20
4 200 0.79 (e51 to 53) 0.98 182 6.1 (e57 to 69) 0.85
5 191 9.7(e23 to 43) 0.56 174 25 (e14 to 65) 0.21
6 185 3.3 (e33 to 40) 0.86 168 17 (e26 to 59) 0.45
7 192 e60 (e110 to e9.8) 0.019 175 e78 (e140 to e15) 0.015
82 206 25 (e34 to 85) 0.40 188 50 (e23 to 123) 0.18
9 198 e40 (e97 to 17) 0.17 180 e47 (e115 to 22) 0.18
10 195 e26 (e68 to 16) 0.22 177 e45 (e95 to 4.3) 0.073
11 187 e31 (e78 to 17) 0.21 172 e34 (e93 to 25) 0.26
12 181 7.4 (e31 to 45) 0.70 164 21 (e24 to 65) 0.37
Study day combinations3
A: days 3e12 195 e8.3 (e26 to 0.88) 0.34 177 e10 (e35 to 14) 0.41
B: days 4e11 195 e9.3 (e27 to 8.9) 0.31 177 e11 (e37 to 14) 0.38
C: days 5e10 195 e7.5 (e27 to 12) 0.45 177 e7.6 (e35 to 19) 0.58
D: days 6e9 195 e13 (e38 to 12) 0.30 177 e15 (e48 to 18) 0.38
E: days 7e8 195 e21 (e59 to 17) 0.27 177 e28 (e78 to 21) 0.26
F: days 7e9 195 e23 (e55 to 8.3) 0.15 177 e34 (e75 to 7.7) 0.11
G: days 7e10 195 e22 (e47 to 4.1) 0.100 177 e36 (e70 to e1.7) 0.039
H: days 7e11 195 e22 (e45 to 1.0) 0.060 177 e35 (e66 to e4.4) 0.025
I: days 6e7 195 e16 (e46 to 13) 0.27 177 e15 (e52 to 21) 0.41
J: days 5e7 195 e4.9 (e28 to 18) 0.67 177 1.2 (e28 to 30) 0.93
K: days 4e7 195 e6.2 (e28 to 16) 0.58 177 e1.1 (-29 to 27) 0.94
L: days 3e7 195 e9.6 (e31 to 12) 0.38 177 e7.7 (e36 to 21) 0.60
M: days 8e9 195 e11 (e51 to 30) 0.60 177 e11 (e63 to 40) 0.66
N: days 8e10 195 e17 (e46 to 122) 0.26 177 e26 (e63 to 11) 0.16
O: days 8e11 195 e18 (e43 to 6.6) 0.15 177 e27 (e59 to 5.4) 0.10
P: days 8e12 195 e9.9 (e32 to 12) 0.38 177 e12 (e40 to 17) 0.42
Boldface indicates statistical significance at P < 0.05.
Abbreviations: CI, confidence interval; DTH, delayed-type hypersensitivity.
1Regression model included the following explanatory variables: age, sex, study site, season, body mass index, physical activity (metabolic equivalent
of task, minutes/week), psychological state (Mental Health Inventoryeglobal index, Profile of Mood States [total mood disturbance], skin reflectance at the
inner arm and left cheek, smoking status, 25-hydroxyvitamin D level (on day of vaccination), lifetime cumulative sun exposure (left hand skin cast grade),
and parental ethnicity (both parents northern European vs. other). DTH data were square-root transformed.
2Day of immunization.
3Using imputed UVR data for days with missing data.
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group and the more modest increase in the high ca-UVR
group suggest an interactive effect of immunization with
UVR exposure.
Recent work has shown that the exposure to UVR triggers a
number of pathways mediated by the aryl hydrocarbon re-
ceptor (Youssef et al., 2019). These include wide-ranging
effects on immune cells, including the proliferation and dif-
ferentiation of Th17 cells (Baricza et al., 2016) and increased
expression of cytokines IL-17 (A and F) and IL-22, particularly
in the setting of antigen processing (Quintana et al., 2008;
Veldhoen et al., 2008). Our observations suggest that
further studies to determine the effect of UVR on antigen-
specific T-cell responses are warranted.
In laboratory studies, the biologically active form of
vitamin D, 1,25 dihydroxyvitamin D, suppresses adaptive
immunity by modulating the differentiation and function of
regulatory T, Th1, and Th17 cells (Wei and Christakos, 2015).
Nevertheless, previous studies assessing the relationshipbetween vitamin D status and antibody response to immu-
nization have shown mixed results (Chadha et al., 2011; Zitt
et al., 2012). Here, we did not observe any association be-
tween 25(OH)D concentration and responses to immuniza-
tion in multivariable analysis, thus supporting the hypothesis
of a direct UVR suppressive effect on the antigen-specific
cell-mediated response.
Our results show that acute personal solar UVR exposure,
occurring during daily activities, modulated the antigen-
specific T-cellemediated immune responses to sensitization
with KLH, a highly immunogenic protein, but had no
detectable effect on antibody responses. Observed changes
in Th17 cell populations related to UVR exposure and im-
munization warrant further work to confirm and extend our
findings. Reduced immune responses to vaccination during
periods of higher natural solar UVR exposure could have
major implications for vaccine efficacy, including that of the
newer epicutaneous delivery systems, particularly for vac-
cines that rely on a cell-mediated immune response.www.jidonline.org 1549
Figure 3. Change in Th17 lymphocytes (as a proportion of all CD4D T cells)
from before to after immunization, according to clothing-adjusted UVR
exposure category. Change in proportion of Th-17 cell subset (as a proportion
of all T helper cells) was calculated by subtracting the preimmunization
percentage from the day 21 postimmunization percentage in individuals with
paired data only. Th, T helper.
Figure 2. Association between clothing-adjusted UVR exposure on the day
before immunization (study day 7) and subsequent DTH response. Each
dot represents a study participant’s clothing-adjusted UVR exposure for study
day 7, the day before KLH immunization. The fitted regression line (dash)
shows the significant inverse correlation between personal UVR exposure
(log 10 scale) and DTH response (square-root transformed) (regression
slope ¼ e0.60 [95% confidence interval ¼ e1.1 to e0.10]; P ¼ 0.02).
DTH, delayed-type hypersensitivity; KLH, keyhole limpet hemocyanin.
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Participants and settings
The AusUVI Study was conducted in two climatically distinct
Australian cities: temperate Canberra, in the Australian Capital Ter-
ritory (35 South latitude) and tropical Townsville, in Queensland
(19 south latitude), with very different ambient UVR (Australian
Government, Bureau of Meteorology, 2019). We recruited healthy
volunteers aged 18e40 years. Exclusion criteria were shellfish al-
lergy, preexisting immunosuppressive condition (e.g., diabetes, HIV
infection, transplant recipient, chronic liver or kidney disease), use
of immunosuppressive agents (systemic agents within 30 days,
topical agents within 7 days), symptoms of infection or vaccination
within 30 days, and pregnancy or breastfeeding.
Study protocol
Recruitment occurred uniformly over a 12-month period to account for
seasonal variation, commencing in July (Southern Hemisphere winter).
Each participant attended five study visits over a 31-day period (Figure 4).
Questionnaire data. On day 1, participants self-reported de-
mographic information including age, sex, ethnicity of each parent,
education level, occupational setting, smoking history, physical ac-
tivity over the previous 7 days (using the International Physical Ac-
tivity Questionnaire [Craig et al., 2003]), and medications, including
vitamin D supplements. On day 8, participants completed the Profile
of Mood States (short form) (Curran et al., 1995) and Mental Health
Inventory (Snyder et al., 1993), which measure psychological well-
being and distress.
Physical examination. On day 1, height and weight were
measured to determine the body mass index. Skin pigmentation was
assessed at the left inner upper arm (i.e., sun-protected site) and left
upper cheek (i.e., sun-exposed site) on days 1, 8, and 15 with a
reflectance spectrophotometer (CM2500d; Minolta, Tokyo, Japan).
Lifetime cumulative UVR exposure. Silicone skin casts were
taken from the dorsum of both hands to assess lifetime cumulative
solar UVR exposure (Cargill et al., 2013).Journal of Investigative Dermatology (2019), Volume 139Sun exposure diary. Participants self-completed a sun exposure
diary (Cargill et al., 2013) daily from days 3e12, inclusive. Time
spent in the sun was recorded in 15-minute intervals. Types of
clothing worn (i.e., for upper and lower body, headwear, footwear,
and gloves) were recorded at hourly intervals, as previously
described (see Supplementary Figure S1 online) (Brodie et al., 2013).
UVR dosimetry. Participants wore an electronic UVR wrist
dosimeter (Seckmeyer et al., 2012) for the 10-day diary period. Wrist
dosimeters have been previously shown to be reliable for recording
personal UVR exposure (Thieden et al., 2000). Dosimeters recorded
erythemally weighted UVR exposure at 8-second intervals between
7 AM and 9 PM. UVR exposure data were integrated to determine the
received UVR dose in SEDs, where 1 SED ¼ 100 Jme2 of erythemally
weighted UVR. Dosimeters were calibrated with a Yankee Environ-
mental Systems erythemal radiometer at the National Institute for
Water and Atmosphere (Lauder, Otago, New Zealand) before and
after study deployment.
KLH immunization. After blood sampling on day 8, participants
were injected subcutaneously at the anterolateral aspect of the
midforearm with 125 mg high-molecular weight KLH (Biosyn Cor-
poration, Carlsbad, CA).
Blood sampling. Blood was collected on days 8, 15, and 29
(Figure 4). Blood samples were assayed at accredited laboratories to
quantify serum renal and liver function, random blood glucose, C-
reactive protein, and full blood count. Sera were stored at e20 C for
analyses of KLH IgG1 and IgG2 titers (days 8, 15, and 29) and
25(OH)D concentration (days 8 and 29) at study completion. Serum
25(OH)D concentration was measured by liquid chromatography-
tandem mass spectrometry (Royal Melbourne Institute of
Technology Drug Discovery Techniques, Melbourne, Australia).
Peripheral blood mononuclear cells were isolated (days 8 and 29)
from whole blood within 16 hours of collection by centrifugation
over a Ficoll step gradient using standard protocols (GE Healthcare
Bio-Sciences AB, 2007). Separated peripheral blood mononuclear
cells were frozen at e80 C and stored in liquid nitrogen.
Figure 4. AusUVI Study Protocol.
Each participant attended five visits
over a 31-day period. Visit 1 included
collection of demographic and
lifestyle information (self-reported),
cutaneous melanin density of sun-
exposed and sun-protected skin, and
silicone skin casts of the backs of the
hands. At visit 2, immunization with
KLH antigen occurred by
subcutaneous injection. Personal UVR
exposure was measured by digital
dosimeter worn on the wrist and
completion of a sun diary for 10 days
(5 days before and 5 days after KLH
immunization). Blood was taken for
KLH antibodies at visits 2, 3 and 4,
and for collection of peripheral blood
mononuclear cells at visits 2 and 4.
DTH testing was undertaken at visit 4
and read 48 hours later at visit 5.
25(OH)D, 25-hydroxyvitamin D;
AusUVI, Australian Ultraviolet
Radiation and Immunity Study; DTH,
delayed-type hypersensitivity; KLH,
keyhole limpet hemocyanin.
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test results suggested systemic inflammation (determined by C-
reactive protein and white cell count greater than three standard
deviations above the study population mean (C-reactive protein
level > 20.7 mg/L, white cell count > 11.3  109/L; n ¼ 5), diabetes
(random blood sugar level > 11.1 mmol/L, n ¼ 0), moderate to se-
vere kidney dysfunction (estimated glomerular filtration rate < 60
mL/min/1.73 m2, n ¼ 0), or moderate liver inflammation (alanine
transaminase level > 120 U/L, n ¼ 0).
Anti-KLH IgG assay. Anti-KLH IgG1 and IgG2 concentrations
were determined by indirect ELISA, as described previously (Grant
et al., 2008). Sera were tested in duplicate (and paired results
averaged) for all three time points, along with a negative and positive
control, on a single ELISA plate. Results were normalized across
assays by dividing the raw absorbance by that plate’s positive control
result, and the background absorbance (defined as the difference in
optical density reading between the negative control and the par-
ticipant’s preimmunization serum [i.e., day 8]) was subtracted from
the day 15 and day 29 readings (Grant et al., 2008).
DTH testing. On day 29, participants received an intradermal
injection of 10 mg KLH at the immunization site. The DTH response
to intradermal KLH injection (an in vivo antigen-specific composite
test of cell-mediated immunity) was measured 48 hours later by
averaging the diameters of induration (in millimeters) along two
perpendicular axes, as previously described (Jordan et al., 1987).
Effector T-cell assays. Effector T-lymphocyte populations (Th1,
Th2, Th17) and regulatory T cells ( CD4þCD25þCD127loFoxp3þ)
were enumerated by flow cytometry. Briefly, 106 peripheral blood
mononuclear cells were stimulated with Leukocyte Activation
Cocktail with Golgi Plug (BD Biosciences, San Jose, CA) for 4 hours;
then cells were surface stained, fixed, and permeabilized according
to the manufacturer’s protocol. For intracellular cytokine (IL-4, IL-17,
IFN-g) staining, cells were incubated on ice with antibodies for 20
minutes, washed, and acquired using the BD FACSCanto flowcytometer (BD Biosciences). For regulatory T cells, after surface
staining, cells were incubated on ice for 30 minutes with Foxp3
antibodies. Data were then analyzed with FlowJo, version 8.7
(FlowJo, Ashland, OR). Antibodies to the following molecules were
used for flow cytometry: CD3 FITC (BD Biosciences), CD4 PerCP
(BD Biosciences), CD25 APC (BD Biosciences), CD127 FITC
(eBioscience, San Diego, CA), Foxp3 PE-CF594 (BD Biosciences), IL-
17 PE (BD Biosciences), IFN-g APC (BD Biosciences), and IL-4 PE
(Miltenyi Biotec, Bergisch Gladbach, Germany).
Statistical analysis
Cutaneous melanin density was estimated from an average of three
reflectance spectrophotometer readings taken at wavelengths of 400
and 420 nm using the formula MD400 ¼ 100[0.035307 þ 0.009974
(R420  R400)] (Dwyer et al., 2002), where MD is the melanin density
and R is reflectance. Skin casts were graded by two independent
scorers (Cargill et al., 2013) (interrater agreement: weighted k
statistic ¼ 0.55), with the average used in analyses.
For missing or clearly erroneous electronic dosimeter data, an
interpolation of estimated personal UVR exposure was calculated
using corresponding sun exposure diary and maximum cloud-
adjusted UVR data (sourced from ground-based UVR monitors
[Biometer Model 501; Solar Light Company, Glenside, PA] situated
at the Australian National University, Canberra, and James Cook
University, Townsville [Liley and Liley, 2010]).
To determine a participant’s personal UVR exposure adjusted for
the body surface area covered by clothing (ca-UVR) (see
Supplementary Figure S1 online) for each hour that the electronic
dosimeter was worn, we used the following formula:
caUVR ¼
X12
i¼ 1
ð1 BSACiÞUVRi
where
 i indexes the hours of the day, from 7 AM e 7 PM;www.jidonline.org 1551
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1552 BSACi is the proportion of the body surface area covered by
clothing for the hour i; determined by summation of clothing
BSAC coefficients for different body regions for that hour (i.e.,
upper body þ lower body þ footwear þ headwear þ gloves)
(theoretical range ¼ 0e1) (Lee and Choi, 2009) (see
Supplementary Table S7 online); and
 UVRi is the UVR measurement from the electronic dosimeter (with
interpolated values) for the hour i.
Agreement of DTH response between assessors was determined
on a subset of participants (n ¼ 22) and was found to be moderate to
strong with a two-way mixed-method intraclass correlation coeffi-
cient of 0.63 (95% CI ¼ 0.38e0.80).
We used mean and standard deviation or median and inter-
quartile range, depending on whether the data were normally
distributed or skewed, to summarize participant demographics, ex-
amination findings, and blood test results. To compare groups, we
used the contingency c2 statistic or Fisher exact test for categorical
data, two-tailed t tests for normally distributed continuous data, and
nonparametric tests (e.g., the Wilcoxon signed-rank test) for non-
normally distributed data. Sinusoidal functions for time of year were
used to adjust for seasonal variation in immune outcome variables at
each study site. We used multiple linear regression or ordinal logistic
regression models to test associations between outcome and expo-
sure variables, adjusting for potential confounders. The best-fitting
regression model was identified by the highest R2 value; P less
than 0.05 was considered statistically significant. Data were
analyzed with the statistical software package Stata, version 12
(StataCorp, College Station, TX).
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Supplementary Figure S1. Clothing options for sun and activity diary. Participants chose an item of clothing from the diagram that best represented clothing
worn for the upper and lower body, head, hands, and feet. This information was recorded in the sun diary over the study period from days 3 to 12. Adapted from
the clothing diary tool developed by the AusD Study Investigator Group for the AusD Study (Brodie et al., 2013).
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Supplementary Table S1. Association between clothing-adjusted UVR exposure over 10 days and potential
immunomodulating variables1
Potential Immune Modulators Subgroup (n)
Clothing-Adjusted UVR SED Range
P-Value2Mean SED – SD SED Range
Overall N ¼ 211 2.1  2.4 0.043e16.8
Sex Male (78) 2.2  2.4 0.051e13.6 0.74
Female (133) 2.1  2.5 0.043e16.8
Site Canberra (106) 1.8  2.2 0.043e13.6 <0.001
Townsville (105) 2.5  2.6 0.13e16.8
Age in years 18e24 (77) 2.1  2.1 0.051e11.1 Reference
25e29 (67) 1.9  1.9 0.043e9.5 0.47
30e34 (30) 2.5  3.5 0.074e16.8 0.89
35e40 (37) 2.3  3.0 0.094e13.6 0.89
Parental ethnicity Northern European (147) 2.5  2.6 0.043e16.8 <0.001
NoneNorthern European (64) 1.3  1.6 0.051e10.1
Indoor/outdoor worker status Indoors (188) 2.1  2.5 0.043e16.8 Reference
Half indoors/half outdoors (19) 2.3  1.3 0.11e5.10 0.15
Outdoors (4) 5.3  3.8 1.6e9.6 0.042
Smoking Nonsmoker (199) 2.1  2.4 0.043e16.8 0.22
Current smoker (12) 3.1  2.7 0.31e9.6
Body mass index Underweight (3) 1.1  1.3 0.13e2.6 0.38
Normal weight (138) 2.2  2.4 0.051e16.8 Reference
Overweight (56) 2.0  2.3 0.043e9.5 0.37
Obese (14) 2.3 3 .4 0.068e11.1 0.57
Psychological profile: POMS (TMD) Below first quartile score (53) 2.8  3.0 0.11e13.6 Reference
Between 1st and 2nd quartiles (58) 1.5  1.6 0.043e9.5 0.005
Between 2nd and 3rd quartiles (43) 2.3  2.3 0.084e9.6 0.57
Above fourth quartile (54) 2.0  2.6 0.051e16.8 0.056
Psychological profile: MHI (global score) Below first quartile score (58) 1.9  2.7 0.043e16.8 Reference
Between 1st and 2nd quartiles (53) 2.0  2.4 0.051e11.1 0.71
Between 2nd and 3rd quartiles (49) 2.5  2.0 0.084e9.5 0.061
Above fourth quartile (48) 2.3  2.7 0.11e13.6 0.27
Physical activity Low activity (13) 2.0  2.9 0.094e10.1 0.99
IPAQ category Moderate activity (71) 1.5  1.3 0.043e6.2 0.28
High activity (126) 2.5  2.8 0.051e16.8 Reference
Vitamin D status in nmol /L,
baseline blood test, day 8
<25 (6) 0.23  0.29 0.043e0.81 <0.001
25e49.9 (32) 0.72  0.63 0.068e2.5 <0.001
50e74.9 (67) 1.9  1.8 0.051e11.1 0.018
>75 (106) 2.8  2.9 0.11e16.8 Reference
Boldface indicates statistical significance at P < 0.05.
Abbreviations: IPAQ, International Physical Activity Questionnaire; MHI, Mental Health Inventory; POMS (TMD), Profile of Mood States (total mood
disturbance); SD, standard deviation; SED, standard erythemal dose.
1N ¼ 211 because six participants did not have cumulative UVR dosimeter data available over this interval.
2Linear regression models using log-transformed UVR exposure distributions and adjusted for season.
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Supplementary Table S2. Association between potential immunomodulatory factors and DTH response
Potential Immune Modulators Subgroup (n)
DTH Response
P-Value1Mean – SD (mm) Range (mm)
Overall N ¼ 2102 7.0  4.0 0e19
Sex Male (79) 6.5  4.2 0e19 0.038
Female (131) 7.4  3.8 0e19
Site Canberra (102) 7.2  4.2 0e19 0.86
Townsville (108) 6.9  3.7 0e19
Season Winter (75) 7.3  4.4 0e19 Reference
Spring (47) 6.8  3.7 0e16 0.61
Summer (37) 7.6  4.0 0e19 0.65
Autumn (51) 6.4  3.5 0e17 0.33
Age (years) 18e24 (79) 6.7  3.9 0e19 Reference
25e 9 (66) 7.3  3.8 0e16 0.39
30e34 (29) 7.1  4.3 0e19 0.69
35e40 (36) 7.3  4.3 0e17 0.61
Parental ethnicity Northern European (both parents) (146) 7.2  3.9 0e17 0.62
Other (64) 7.0  4.0 0e19
Melanin density, left inner arm,
lightest to darkest skin
Quartile 1 (52) 7.5  4.1 0e17.5 Reference
Quartile 2 (51) 6.2  3.6 0e19 0.16
Quartile 3 (50) 7.1  4.0 0e19 0.71
Quartile 4 (55) 7.3  4.2 0e17 0.74
Melanin density, left upper cheek,
lightest to darkest skin
Quartile 1 (54) 6.5  3.3 0e13.5 Reference
Quartile 2 (56) 7.4  3.9 2e17.5 0.29
Quartile 3 (44) 6.4  4.5 0e17 0.59
Quartile 4 (53) 8.0  4.2 0e19 0.11
Smoking Nonsmoker (199) 7.0  4.0 0e19 0.74
Current smoker (11) 7.1  2.9 2e13
Body mass index categories Underweight (4) 6.5  1.9 4e8.5 0.87
Normal weight (136) 7.2  3.9 0e19 Reference
Overweight (55) 6.4  4.4 0e17.5 0.69
Obese (15) 7.9  3.0 3.5e14 0.58
Psychological profile: POMS (TMD),
lowest to highest mood disturbance
Quartile 1 (54) 7.0  4.1 0e19 Reference
Quartile 2 (56) 7.5  4.1 0e17.5 0.46
Quartile 3 (44) 6.8  4.5 0e19 0.67
Quartile 4 (53) 6.6  3.3 0e17 0.81
Psychological profile: MHI (global score),
lowest to highest well-being
Quartile 1 (57) 6.5  3.8 0e19 Reference
Quartile 2 (53) 7.9  4.3 0e17.5 0.083
Quartile 3 (47) 6.9  4.0 0e16 0.65
Quartile 4 (50) 6.6  3.9 0e19 0.86
Physical activity, IPAQ category Low activity (12) 6.1  4.8 0e14 0.26
Moderate activity (70) 7.3  4.2 0e19 0.79
High activity (128) 7.0  3.8 0e19 Reference
25(OH)D level in nmol/L at baseline, day 8 <25 nmol /L (6) 7.2  7.8 0e14 0.99
25e49.9 nmol /L (31) 7.4  4.6 0e19 0.71
50e74.9 nmol/L (65) 7.4  4.4 0e19 0.56
>75 nmol /L (108) 6.7  3.5 0e17 Reference
Boldface indicates statistical significance at P < 0.05.
Abbreviations: 25(OHD, 25-hydroxyvitamin D; DTH, delayed-type hypersensitivity; IPAQ, International Physical Activity Questionnaire; MHI, Mental
Health Inventory; POMS (TMD), profile of mood states (total mood disturbance).
1Parametric testing or regression performed with square-root transformed distribution of DTH responses.
2Seven participants were excluded from this analysis: six who were not evaluated for DTH response and one with an extreme DTH response (29.5 mm).
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Supplementary Table S3. Combinations of UVR exposure daily totals used for regression models1
Day Combinations
Analyzed2
Study Days Electronic Dosimeter Worn
3 4 5 6 7 83 9 10 11 12
A 3 4 5 6 7 8 9 10 11 12
B 4 5 6 7 8 9 10 11
C 5 6 7 8 9 10
D 6 7 8 9
E 7 8
F 7 8 9
G 7 8 9 10
H 7 8 9 10 11
I 6 7
J 5 6 7
K 4 5 6 7
L 3 4 5 6 7
M 8 9
N 8 9 10
O 8 9 10 11
P 8 9 10 11 12
1Only days with complete UVR data (i.e., no missing data) were used to generate the aggregated combinations of days. To make this aggregated-day data set
as complete as possible, missing daily totals that remained after the interpolation process were replaced by a simplified imputation method (based on the
average of the remaining days that had complete data, differentiated by weekday and weekend). This most complete data set comprised 10 days of daily
UVR exposure totals for 216 participants.
2Aggregated daily UVR exposure totals (measured þ interpolated þ imputed).
3Day of immunization.
Supplementary Table S4. T-helper cell subsets (%) before and after immunization by UVR exposure group
T-Helper Subset1
Cell Surface Markers/Intracellular
Cytokine or Transcription Factor
Preimmunization Postimmunization
Median % (IQR) Median % (IQR)
Low UVR
(n [ 27)
High UVR
(n [ 28) P2
Low UVR
(n [ 24)
High UVR
(n [ 26) P2
Th1 CD3þCD4þ/IFN-g 5.4 5.8 0.95 5.3 7.9 0.12
(2.3e10.8) (3.1e10.1) (1.7e7.7) (3.1e11.4)
Th2 CD3þCD4þ/IL-4 0.28 0.51 0.13 0.31 0.27 0.35
(0.12e0.53) (0.19e0.80) (0.00e0.51) (0.11e0.67)
Th17 CD3þCD4þ/IL-17 0.75 0.56 0.13 0.54 0.62 0.38
(0.25e1.49) (0.18e0.81) (0.15e1.13) (0.27e1.25)
Treg CD3
þCD4þCD25þCD127loFoxp3þ 0.06 0.05 0.11 0.05 0.052 0.63
(0.04e0.07) (0.04e0.07) (0.04e0.08) (0.04e0.06)
Abbreviations: IQR, interquartile range; Th, T helper; Treg, T regulatory cell.
1T-helper subsets are expressed as a percentage of total T-helper cells (CD3þCD4þ).
2Wilcoxon rank-sum test of low versus high UVR group (unpaired) samples. The P-values pertain to a comparison of helper T-cell subset concentration in the
low versus high clothing-adjusted UVR exposure groups, before and after immunization. They are unpaired (and nonparametric in distribution).
A Swaminathan et al.
UVR and Response to Immunization
www.jidonline.org 1553.e4
Supplementary Table S5. Association between clothing-adjusted UVR exposure on individual study days and
combinations of days and anti-KLH IgG1 response (measured at day 21 after immunization)
Day
Univariate Linear Regression Multivariable Linear Regression1
n b (95%CI), 310-3 P n b (95%CI), 310-3 P
Individual study day
3 204 113 (e164 to 391) 0.42 188 e53 (e384 to 278) 0.75
4 205 165 (e41 to 372) 0.12 187 197 (e33 to 426) 0.093
5 196 1.4 (e119 to 147) 0.83 178 42 (e104 to 188) 0.57
6 190 e0.72 (e152 to 150) 0.99 173 e46 (e211 to 119) 0.58
7 197 3.9 (e169 to 248) 0.71 180 e11 (e249 to 226) 0.93
82 211 e6.8 (e308 to 171) 0.57 193 e145 (e413 to 122) 0.29
9 203 7.8 (e157 to 314) 0.51 185 94 (e158 to 347) 0.46
10 200 112 (e5.5 to 280) 0.19 182 36 (e146 to 219) 0.70
11 192 1.0 (e179 to 200) 0.92 177 6.9 (e205 to 219) 0.95
12 185 3.2 (e111 to 175) 0.66 168 38 (e110 to 186) 0.61
Study day combinations3
A: days 3e12 200 3.5 (e3.5 to 105) 0.33 182 16 (e75 to 107) 0.72
B: days 4e11 200 3.3 (e42 to 108) 0.38 182 e19 (e77 to 115) 0.70
C: days 5e10 200 3.0 (e51 to 112) 0.46 182 8.7 (e93 to 111) 0.87
D: days 6e9 200 6.5 (e9.6 to 109) 0.90 182 e22 (e147 to 102) 0.72
E: days 7e8 200 e12 (e170 to 146) 0.88 182 e61 (e249 to 127) 0.52
F: days 7e9 200 7.4 (e122 to 137) 0.91 182 e12 (e170 to 146) 0.88
G: days 7e10 200 3.4 (e7.3 to 140) 0.53 182 0.35 (e130 to 130) 1.0
H: days 7e11 200 2.4 (e7.2 to 119) 0.63 182 e1.4 (e119 to 116) 0.98
I: days 6e7 200 2.1 (e101 to 143) 0.73 182 0.088 (e139 to 139) 1.0
J: days 5e7 200 3.1 (e6.2 to 125) 0.51 182 27 (e82 to 136) 0.63
K: days 4e7 200 4.5 (e4.4 to 135) 0.32 182 48 (e59 to 154) 0.38
L: days 3e7 200 4.7 (e4.1 to 134) 0.30 182 38 (e70 to 145) 0.49
M: days 8e9 200 e1.8 (e184 to 147) 0.83 182 e39 (e232 to 155) 0.69
N: days 8e10 200 2.6 (e9.4 to 145) 0.68 182 e19 (e160 to 122) 0.79
O: days 8e11 200 1.4 (e8.9 to 117) 0.79 182 e17 (e140 to 107) 0.79
P: days 8e12 200 1.9 (e7.0 to 108) 0.68 182 e6.2 (e111 to 98) 0.91
Abbreviations: CI, confidence interval; IgG, immunoglobulin G.
1Regression model included the following explanatory variables: age, sex, study site, season, BMI, physical activity (MET-minutes/week), psychological state
(MHI-global index, POMS-TMD), skin reflectance at the inner arm and left cheek, smoking status, 25(OH)D level (on day of vaccination), life-course UVR
exposure (left hand skin cast grade), parental ethnicity (both parents northern European vs. other). Natural logarithm-transformed data were used for in-
dividual days and combinations of days to normalize the highly negatively skewed UVR exposure data.
2Day of immunization.
3Using imputed UVR data for missing days.
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Supplementary Table S6. Association between clothing-adjusted UVR exposure on individual study days and
combinations of days and anti-KLH IgG2 response (measured at day 21 after immunization)
Day
Univariate Linear Regression Multiple Variable Linear Regression1
n b (95%CI), 310-3 P n b (95%CI), 310-3 P
Individual study day
3 200 e117 (e349 to 115) 0.32 185 e 46 (e 331 to 239) 0.75
4 202 23 (e143 to 19) 0.78 184 146 (e 41 to 333) 0.13
5 193 e41 (e145 to 61) 0.42 176 60 (e 57 to 176) 0.31
6 187 e30 (e147 to 86) 0.61 170 e 13 (e 117 to 142) 0.85
7 194 152 (e323 to 17) 0.79 177 e74 (e 270 to 123) 0.46
82 208 e62 (e271 to 146) 0.55 190 e 41 (e 278 to 196) 0.73
9 200 e35 (e253 to 182) 0.75 182 88 (e 151 to 327) 0.47
10 197 73 (e68 to 214) 0.31 179 123 (e 28 to 274) 0.11
11 189 e16 (e170 to 138) 0.84 174 101 (e 73 to 276) 0.25
12 183 44 (e66 to 156) 0.43 166 90 (e 25 to 204) 0.12
Study day combinations3
A: days 3e12 197 e8.4 (e65 to 48) 0.77 179 e43 (e29 to 117) 0.24
B: days 4e11 197 e19 (e79 to 42) 0.54 179 33 (e44 to 111) 0.40
C: days 5e10 197 e21 (e87 to 44) 0.52 179 33 (e50 to 116) 0.43
D: days 6e9 197 e44 (e13 to 41) 0.31 179 e14 (e117 to 90) 0.80
E: days 7e8 197 e100 (e232 to 31) 0.14 179 e74 (e234 to 85) 0.36
F: days 7e9 197 e74 (e185 to 37) 0.19 179 e33 (e169 to 103) 0.63
G: days 7e10 197 e27 (e116 to 63) 0.56 179 19 (e90 to 129) 0.73
H: days 7e11 197 e28 (e107 to 51) 0.49 179 23 (e74 to 120) 0.64
I: days 6e7 197 e58 (e156 to 40) 0.24 179 e24 (e136 to 89) 0.68
J: days 5e7 197 e35 (e110 to 40) 0.36 179 26 (e62 to 114) 0.57
K: days 4e7 197 e27 (e98 to 44) 0.45 179 35 (e50 to 122) 0.41
L: days 3e7 197 e31 (e101 to 39) 0.39 179 31 (e55 to 119) 0.48
M: days 8e9 197 e45 (e193 to 102) 0.54 179 e7.9 (e169 to 185) 0.93
N: days 8e10 197 47 (e97 to 107) 0.93 179 56 (e65 to 177) 0.36
O: days 8e11 197 e8.5 (e94 to 77) 0.84 179 47 (e56 to 150) 0.36
P: days 8e12 197 14 (e58 to 88) 0.69 179 61 (e24 to 146) 0.16
1Regression model included the following explanatory variables: age, sex, study site, season, BMI, physical activity (MET-minutes/week), psychological state
(Mental Health Inventory-global index, profile of mood states (total mood disturbance), skin reflectance at the inner arm and left cheek, smoking status,
25(OH)D level (on day of vaccination), life-course UVR exposure (left hand skin cast grade), parental ethnicity (both parents northern European vs. other).
2Day of immunization.
3Using imputed UVR data for missing days.
Supplementary Table S7. Assigned body surface area covered coefficients for individual clothing types1
Clothing Type 0 1 2 3 4 5 6
Upper body No clothing Bikini top Swimsuit top Crop top Singlet top Short-sleeved top Long-sleeved top
0 0.041 0.354 0.128 0.207 0.254 0.358
Lower body No clothing Speedos/briefs Shorts or
short skirt
Medium shorts
or 3/4-length pants
Long trousers/
jeans
Medium skirt Long skirt
0 0.070 0.200 0.294 0.423 0.304 0.431
Headwear No headwear Beanie Cap Legionnaire’s cap Bucket hat Wide-brimmed hat Veil/burka
0 0.049 0.049 0.061 0.054 0.071 0.065
Footwear No footwear Thongs/open
sandals
Semi-enclosed
shoes
Enclosed shoes Work boots Long socks
0 0.032 0.056 0.077 0.111 0.154
Gloves No gloves Gloves
0 0.049
1Adapted from Lee and Choi, 2009.
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